Positive Visx says Icahn has "nothing new"
This article was originally published in Clinica
Ophthalmic laser company Visx says its earnings-per-share for the first quarter will be $0.20-$0.21 - compared with analysts' expectations of $0.18 - due in part to a sequential 23% increase in licensing revenues. The good news compares with a profit warning for the previous quarter (see Clinica No 940, p 14). At the same time, the company has urged shareholders not to accept financier Carl Icahn's proxy nominees for the board.